Article | June 22, 2016

Built To Fail: How Today's Manufacturing Options Leave Pharma At Risk

Source: Patheon, part of Thermo Fisher Scientific

By Joe Principe

pharmaceutical manufacturing development

By Joe Principe, Vice President, Strategic Partnerships, Patheon

When planning for the development of a new product, a pharmaceutical manufacturer must determine very early in the process what a product’s anticipated demand will be at the time of launch. Not only is this very difficult to do, but also the consequences of incorrect forecasts can be very costly in a number of ways. Without the ability to predict capacity needs with 100% accuracy, pharma must come up with an effective way to eliminate demand risks.

Patheon, part of Thermo Fisher Scientific